Patients, methods, and results
The Ley Community is a therapeutic community with facilities for residential treatment of 30-40 young people. Previous studies of the patients reported on here showed that they were mainly x oung unmarried men and women who had left school early and had been taking various drugs for over three years.1 2
Most had a history of regular injections of opiates and several criminal convictions. Middle class backgrounds, an unstable work history coupled with underachievement, average intelligence, and personality characteristics associated with delinquency were common features.2
The 61 people admitted from 1971 to 1973 were followed up and divided into three groups: short stay (under one month), medium stay (under six months), and long stay (over six months). These groups were compared on admission with regard to demographic characteristics, history of criminality, and history of drug use and did not differ significantly.' Ten years after discharge a search was made of the records of each subject in the Criminal Records Office, Scotland Yard, and the presence of subjects on general practitioners' lists and any deaths were noted through the National Health Service central register.
Sixty of the 61 people were traced. Fifty one were on a general practitioner's list, two were in prison, one was in Australia, and six were dead. The long stay group had significantly fewer convictions after discharge than before (p < 0-001), even when convictions precipitating admission were excluded (table). Only three of the 20 long stay patients had been reconvicted, whereas 32 of the remaining 41 patients had been cWnvicted (A2= 19-35, r< 0-001).
Of the six patients who had died, four (short stay group) had died as a result of drugs, one (medium stay group) had died of natural causes, and one (long stay group) had committed suicide unrelated to drugs.
Comment
Drug addicts are notoriously difficult to treat, and the associated criminality is even more resistant to treatment. Gordon found that 83 % of a sample of patients who presented to a London drug clinic were convicted during 10 years of follow up and a high rate of conviction persisted even after they had given up drugs.3 Similarly, Weipert et al found that clinic treatment had no effect on the future crime rate and that during treatment the proportion of drug offences actually increased.4
The proportion of our subjects who were reconvicted during 10 years' follow up (57%) contrasts considerably with these findings. Our relatively low conviction rate is clearly largely accounted for by the remarkably low reconviction rate in the long stay group (15%). The reconviction rates in the medium stay group (70%) and short stay group (85%o) are typical of rates in other studies. Can the success of the long stay group be attributed to their treatment? This group, though highly self selected, did not differ from the others in criminal history, drug abuse, personality, intelligence, or demographic factors, which argues strongly in favour of a treatment effect resulting from a long period of residence in the therapeutic community.
The methodological pitfalls in evaluating treatment programmes for drug addiction are numerous and were discussed by Wilson.5 In particular, the willingness of people to stay in the unit may be related to the fact that they are less likely to reoffend anyway. Nevertheless, evidence suggests that those who stay for over six months show a significant reduction in personality disturbance.' The low conviction rate in the long stay group reported after two years3 5 was maintained for 10 years, which is undeniably impressive.
Therapeutic communities remain a promising-perhaps the most promising-treatment option for addicts willing to submit to a substantial period of residence. They deserve more attention from researchers and policy makers. cells (myeloid to erythroid ratio 1:1), normal megakaryocytes, and no malignant cells. She was successfully treated with antibiotics and the white cell count recovered to >3 Ox 109/1 12 days after stopping aminoglutethimide with an associated thrombocytosis of 985 X 109/1. Three weeks after stopping aminoglutethimide bone marrow aspirate and peripheral blood cell count were normal, and four months later she remained well with a normal blood count and no evidence of recurrent carcinoma. Since 1978 this patient has been taking chlorthalidone (50 mg/day) for mild hypertension, which she continued with no adverse reaction.
Case 3-On 29 December 1982 a 67 year old woman developed agranulocytosis (white cell count 0-1 X 109/1) with a haemoglobin concentration of 9 7 g/dl and a platelet count of 272 x 109/l (figure). She had been taking adjuvant aminoglutethimide for 60 days. She was asymptomatic apart from mild monilial stomatitis. Although there was no evidence of septicaemia, she was admitted for observation and prophylaxis with antibiotics. Bone marrow aspirate was hypocellular with absent myeloid precursors, scanty erythroid precursors, and occasional megakaryocytes with no malignant cells. Nineteen days after stopping aminoglutethimide her white cell count had recovered to 6-4X 109/l with an associated thrombocytosis (534X 109/l).
Eight months later she remained well with a normal blood cell count and no evidence of recurrent carcinoma. She had also taken ferrous sulphate (200 mg/ day) and occasional metoclopramide (10 mg) and diazepam (2 mg) in the weeks before developing agranulocytosis.
These three patients developed agranulocytosis five to eight weeks after starting aminoglutethimide and hydrocortisone. None had evidence of metastases and we therefore presume that the cause of bone marrow failure was drug toxicity by aminoglutethimide. Although serious and potentially fatal, the condition is uncommon (roughly 2% of cases) and reversible on stopping treatment. The reduction in granulocytes and other precursors in the bone marrow may indicate a direct toxic effect of the drug rather than immune peripheral destruction. This is consistent with the relatively rapid recovery associated with a rebound thrombocytosis. Finally, the serial blood counts in case 2 showed a gradual decrease in white cells. Case report A 20 year old girl was admitted with an exacerbation of Crohn's disease. Owing to the severity of her condition she was treated with intravenous steroids and antibiotics, and a parenteral feeding regimen was begun through a right subclavian line. She steadily improved clinically and was beginning to tolerate oral feeding. After two weeks the subclavian line was due to be removed, but unexpectedly the nurses found her unconscious on the floor of her single room. She had obviously fallen from a bedside commode. She had probably removed the subclavian line (she was unable to recall the event, but disliked the line). The plastic introducer was still in situ th-ough the skin, with blood leaking from it. She had probably been in that position for less than five minutes.
She had signs of severe cerebral irritation, with fixed dilated pupils, extensor limb response to pain, and extreme restlessness. Her reflexes were brisk, but the plantars were downgoing. Her pulse rate was 110/minute and blood pressure 85 mm Hg systolic. Her respiratory rate was raised. Funduscopy yielded normal results, and the only other abnormal finding was a churning noise in the chest on auscultation. Air embolism was diagnosed. She was initially treated with high dose oxygen, dexamethasone, mannitol, and diazepam and was transferred to the intensive care unit.
